Phase I/II Study of 5-Aza-2'-Deoxycytidine and Valproic Acid in Patients With Relapsed/Refractory Leukemia or Myelodysplastic Syndromes.
Phase of Trial: Phase I/II
Latest Information Update: 23 Nov 2018
At a glance
- Drugs Decitabine (Primary) ; Valproic acid (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 11 Aug 2009 Eisai Medical Research added as trial sponsor and lead trial centre as reported by ClinicalTrials.gov.
- 09 Jun 2009 Actual end date changed from Feb 2006 to Nov 2006 as reported by ClinicalTrials.gov.